|
|
Previous Article | Table of Contents | Next Article 
De Novo CD5+ Diffuse Large B-Cell Lymphomas Express
VH Genes With Somatic Mutation
Masanori Taniguchi,
Kouji Oka,
Atsunori Hiasa,
Motoko Yamaguchi,
Toshiyuki Ohno,
Kenkichi Kita, and
Hiroshi Shiku
From The Second Department of Internal Medicine, Mie University
School of Medicine, Tsu, Japan.
To clarify the cellular origin of de novo CD5+ diffuse
large B-cell lymphoma (CD5+ DLBL), particularly in
comparison with other CD5+ B-cell neoplasms such as
chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL), we
analyzed the nucleotide sequence of the Ig heavy chain variable region
(IgVH) genes of de novo CD5+ DLBL cases. All 4 cases
examined had extensive somatic mutations in contrast with CLL or MCL.
The VH gene sequences of de novo CD5+ DLBL displayed
86.9% to 95.2% homology with the corresponding germlines, whereas
those of simultaneously analyzed CLL and MCL displayed 97.6% to 100%
homology. The VH family used was VH3 in 1 case, VH4 in 2 cases, and VH5
in 1 case. In 2 of 4 examined cases, the distribution of replacement
and silent mutations over the complementarity determining region and
framework region in the VH genes was compatible with the pattern
resulting from the antigen selection. Clinically, CD5+
DLBL frequently involved a variety of extranodal sites (12/13) and
lymph node (11/13). Immunophenotypically, CD5+ DLBL
scarcely expressed CD21 and CD23 (3/13 and 2/13, respectively). These
findings indicate that de novo CD5+ DLBL cells are
derived from a B-1 subset distinct from those of CLL or MCL.
Blood, Vol. 91 No. 4 (February 15), 1998:
pp. 1145-1151
© 1998 by The American Society of Hematology.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Yamamoto, Y. Wada, Y. Ishikawa, and K. Kadota
Precursor B-1 B cell lymphoma in a newborn calf
J Vet Diagn Invest,
July 1, 2007;
19(4):
447 - 450.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. S. Lossos and D. Morgensztern
Prognostic Biomarkers in Diffuse Large B-Cell Lymphoma
J. Clin. Oncol.,
February 20, 2006;
24(6):
995 - 1007.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Katzenberger, A. Lohr, S. Schwarz, M. Dreyling, J. Schoof, C. Nickenig, S. Stilgenbauer, J. Kalla, M. M. Ott, H. K. Muller-Hermelink, et al.
Genetic analysis of de novo CD5+ diffuse large B-cell lymphomas suggests an origin from a somatically mutated CD5+ progenitor B cell
Blood,
January 15, 2003;
101(2):
699 - 702.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kobayashi, M. Yamaguchi, S. Kim, J. Morikawa, S. Ogawa, S. Ueno, E. Suh, E. Dougherty, I. Shmulevich, H. Shiku, et al.
Microarray Reveals Differences in Both Tumors and Vascular Specific Gene Expression in de Novo CD5+ and CD5- Diffuse Large B-Cell Lymphomas
Cancer Res.,
January 1, 2003;
63(1):
60 - 66.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Yamaguchi, M. Seto, M. Okamoto, R. Ichinohasama, N. Nakamura, T. Yoshino, J. Suzumiya, T. Murase, I. Miura, T. Akasaka, et al.
De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients
Blood,
February 1, 2002;
99(3):
815 - 821.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. S. Lossos, R. Tibshirani, B. Narasimhan, and R. Levy
The Inference of Antigen Selection on Ig Genes
J. Immunol.,
November 1, 2000;
165(9):
5122 - 5126.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. S. Lossos, A. A. Alizadeh, M. B. Eisen, W. C. Chan, P. O. Brown, D. Botstein, L. M. Staudt, and R. Levy
Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas
PNAS,
August 17, 2000;
(2000)
180316097.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
I. S. Lossos, C. Y. Okada, R. Tibshirani, R. Warnke, J. M. Vose, T. C. Greiner, and R. Levy
Molecular analysis of immunoglobulin genes in diffuse large B-cell lymphomas
Blood,
March 1, 2000;
95(5):
1797 - 1803.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Capello, U. Vitolo, L. Pasqualucci, S. Quattrone, G. Migliaretti, L. Fassone, C. Ariatti, D. Vivenza, A. Gloghini, C. Pastore, et al.
Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia
Blood,
January 15, 2000;
95(2):
651 - 659.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Novelli, M. Ramírez, W. Leung, and C. I. Civin
Human Hematopoietic Stem/Progenitor Cells Generate CD5+ B Lymphoid Cells in NOD/SCID Mice
Stem Cells,
September 1, 1999;
17(5):
242 - 252.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. R. Thompsett, D. W. Ellison, F. K. Stevenson, and D. Zhu
VH Gene Sequences From Primary Central Nervous System Lymphomas Indicate Derivation From Highly Mutated Germinal Center B Cells With Ongoing Mutational Activity
Blood,
September 1, 1999;
94(5):
1738 - 1746.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. S. Lossos, A. A. Alizadeh, M. B. Eisen, W. C. Chan, P. O. Brown, D. Botstein, L. M. Staudt, and R. Levy
Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas
PNAS,
August 29, 2000;
97(18):
10209 - 10213.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|